The archive

All stories

484 stories, newest first — page 1 of 21.

Latest briefs

Illustration of a bladder and intravesical treatment catheter beside a pathology report marked high-grade papillary disease.

Oncology

Anktiva Expands for Papillary-Only Bladder Cancer

The FDA expanded Anktiva plus BCG to adults with BCG-unresponsive, high-grade papillary non-muscle-invasive bladder cancer without carcinoma in situ.

Rayan Salih · 6 min read

Packaged intraosseous access supplies being checked against an inventory list in an emergency department.

Innovation & Devices

Intraosseous Needle Recall Prompts Emergency Stock Review

The FDA recall affects specified Becton Dickinson intraosseous needle sets. Hospitals and emergency services should identify recalled stock while maintaining dependable alternatives for urgent vascular access.

Rayan Salih · 6 min read

An automated Impella controller undergoing an identification-label check in a hospital cardiac procedure area.

Cardiology

Impella Controller Recall: Immediate Cath Lab Checks

Cardiac procedural teams should reconcile every automated Impella controller against the FDA-listed removal, including units in use, storage, transport kits and biomedical engineering custody.

Rayan Salih · 7 min read

Oncology

Atezolizumab Approved for Stage III dMMR Colon Cancer

The FDA approved adjuvant atezolizumab plus chemotherapy after resection of stage III dMMR colon cancer in adults and patients aged 12 years or older. The subcutaneous formulation is limited to adults.

Rayan Salih · 6 min read

A pathology workstation displaying a genomic sequencing report beside a tumor tissue slide.

Oncology

Pembrolizumab Gains Traditional Approval in TMB-High Tumors

The FDA action covers adults and children with unresectable or metastatic solid tumors measuring at least 13 mutations/Mb after prior progression when satisfactory alternatives are unavailable.

Rayan Salih · 7 min read

Prostate cancer pathology slide beside a molecular test report and medication packaging in a clinical laboratory.

Oncology

Prostate Cancer Approval Expands Talazoparib Eligibility

The FDA has expanded talazoparib plus enzalutamide to selected adults with HRR-mutated metastatic castration-sensitive prostate cancer. Treatment requires mutation confirmation with an FDA-authorized test.

Rayan Salih · 7 min read

Urine specimen cup beside a kidney function laboratory request and glucose meter on a clinical desk.

Endocrinology & Metabolism

Finerenone Opens Kidney Protection Path in Type 1 Diabetes

The FDA has approved finerenone for renal protection in adults with type 1 diabetes and chronic kidney disease, using albuminuria reduction as the basis for the new pathway.

Rayan Salih · 6 min read

Oncology

Dostarlimab Gains Accelerated Approval in Rectal Cancer

The indication covers adults with stage II or III locally advanced rectal cancer that is MSI-H or dMMR, as established with an FDA-authorized test.

Rayan Salih · 6 min read

Clinicians reviewing a pulmonary angiogram and coordinated pulmonary embolism care pathway

Cardiology

Pulmonary Embolism Guideline Reframes Severity and Teams

The first consolidated US multisociety guideline for adults with acute pulmonary embolism introduces an A-to-E severity taxonomy and gives Pulmonary Embolism Response Teams a class 1 recommendation.

Dr. Abu Bakar · 7 min read

Hepatitis B laboratory results beside antiviral medication and a liver assessment form

Infectious Disease

Defining Bepirovirsen Candidates in Chronic Hepatitis B

The FDA approved bepirovirsen for certain adults with chronic hepatitis B without cirrhosis. It is added to established antiviral therapy, not substituted for it.

Dr. Abu Bakar · 7 min read

A prostate cancer pathology specimen beside a genomic testing report and medication containers.

Oncology

Prostate Cancer: HRR Testing Defines Talazoparib Use

The verified FDA indication covers adults with HRR gene-mutated metastatic castration-resistant prostate cancer, making an approved companion diagnostic essential before talazoparib plus enzalutamide.

Dr. Abu Bakar · 6 min read

Echocardiography image and transcatheter heart-valve model arranged in a clinical valve-team workspace.

Cardiology

TAVR Reduces Events in At-Risk Moderate Aortic Stenosis

In a randomized trial, TAVR lowered the two-year risk of death or heart-failure hospitalization in patients with moderate aortic stenosis and at-risk features.

Dr. Abu Bakar · 6 min read

A laryngoscope and clinical notes beside a stylized plasmid DNA model in an airway treatment room.

Innovation & Devices

Voceryq Enters Care for Recurrent Respiratory Papillomatosis

The FDA has granted accelerated approval to plasmid DNA-based Voceryq for adults with HPV-associated recurrent respiratory papillomatosis, adding an option while confirmatory evidence is developed.

Dr. Abu Bakar · 6 min read

Medication tablets beside a heart model and a left atrial appendage closure device package.

Cardiology

Single-Agent Therapy After Left Atrial Appendage Closure: What the SIMPLAAFY Trial Found

SIMPLAAFY compared reduced-dose oral anticoagulation or aspirin alone with dual antiplatelet therapy after left atrial appendage closure, finding similar stroke rates and less bleeding over 6 months.

Dr. Abu Bakar · 6 min read

A breast cancer molecular testing report beside labeled pathology slides and an oncology treatment plan.

Women's Health

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Breast Cancer

The FDA indication ties imlunestrant plus abemaciclib to an ESR1-positive result after endocrine therapy progression in ER-positive, HER2-negative advanced breast cancer.

Rayan Salih · 6 min read

Intravenous iron infusion supplies beside a laboratory tube labeled for serum phosphate testing.

Endocrinology & Metabolism

Ferric Carboxymaltose Gets Boxed Warning for Low Phosphate

The FDA has elevated the hypophosphatemia warning for ferric carboxymaltose, affecting iron selection, patient counseling and phosphate evaluation.

Rayan Salih · 6 min read

A transcatheter valve delivery system prepared on a sterile structural-heart procedure table.

Cardiology

FDA Flags Edwards Mitral Delivery-System Safety Issue

An FDA early alert concerns an Edwards transcatheter mitral-valve delivery system, but key scope and response details remain unavailable to structural-heart teams.

Rayan Salih · 6 min read

Cardiology

Edwards Mitral Valve Delivery-System Alert Needs Review

An FDA early alert flags an Edwards transcatheter mitral-valve delivery system, but the available record does not name a model, event count or corrective action.

Dr. Abu Bakar · 6 min read

Intravenous iron vial beside a laboratory phosphate result and infusion supplies on a clinical work surface.

Endocrinology & Metabolism

Ferric Carboxymaltose Boxed Warning Elevates Phosphate Risk

The FDA boxed warning highlights serious hypophosphatemia with ferric carboxymaltose, particularly after repeated exposure. Treatment selection should now include phosphate risk, counseling and monitoring needs.

Dr. Abu Bakar · 7 min read

Cardiology

Aortic Stenosis Trial Will Test Beta-Blocker Effects

The multicenter BASE trial will test cardiovascular and metabolic effects of beta-blocker therapy in people with aortic stenosis. Its protocol does not yet provide treatment-effect estimates.

Rayan Salih · 6 min read

A weekly medication organizer beside an insulin pen and glucose meter on a clinical desk.

Endocrinology & Metabolism

Type 2 Diabetes Gains a Once-Weekly Insulin Option

FDA approval of insulin efsitora alfa-gobe creates a weekly basal insulin option for adults with type 2 diabetes, making treatment burden, hypoglycemia risk and follow-up capacity central to selection.

Rayan Salih · 7 min read

Rectal cancer imaging and pathology materials beside an immunotherapy vial in a clinical review setting.

Health Policy

Dostarlimab’s Accelerated Approval in Rectal Cancer

The FDA authorized dostarlimab for eligible adults with stage II or III locally advanced rectal cancer, based on a 154-patient efficacy assessment. Confirmation of long-term clinical benefit is still required.

Rayan Salih · 7 min read

Sealed procedure kits and antiseptic applicators being checked against a hospital recall inventory list.

Infectious Disease

Convenience Kit Recall: FDA Classifies Medline’s BD ChloraPrep-Related Recall as Class I

The Class I recall applies to specified Medline convenience kits containing recalled BD ChloraPrep applicators. Hospitals and other users should match both kit identifiers and lots against the FDA notice.

Dr. Abu Bakar · 6 min read

Prostate cancer tissue testing materials beside sealed talazoparib and enzalutamide medication packages

Oncology

Talazoparib Plus Enzalutamide for HRR-Mutated Prostate Cancer

The FDA approved talazoparib plus enzalutamide for adults with HRR-mutated metastatic prostate cancer that remains naïve or sensitive to androgen-pathway modulation. An FDA-authorized test must confirm eligibility.

Dr. Abu Bakar · 7 min read